CareDx, Inc.

CareDx, Inc. develops diagnostic solutions for transplant patients and caregivers globally. Products include AlloSure Kidney, Heart, and Lung, which use cell-free DNA technology. The company also offers Olerup SSP, QTYPE, Ottr, AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, Allocell, XynQAPI, and AlloCare. Products are sold directly or through third-party distributors. CareDx has a license agreement with Illumina for NGS products and Cibiltech for iBox software. The company was formerly known as XDx and changed its name in 2014. It is headquartered in South San Francisco, California.

Overview

Sector

Healthcare

Target Price

0.0 USD

Current Price

12.9 USD

Potential

-100%

Strengths

Current Price to Earnings Ratio (13.26) is lower than the sector mean (67.88).
Price to book ratio (1.84) is lower than the sector mean (9.96).

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.
EV/EBITDA (100.00) is significantly higher than the sector mean (36.02).
EV/EBIT (100.00) is significantly higher than the sector mean.
EBITDA Margin (0.00%) appears relatively low.

Key Financial Data

Indicator	Value
PER	13.4
EV/EBITDA	100.0
Price/Free Cash Flow'	22.3
ROIC	9.4%
Net Debt/EBITDA	0.7